How the US drug safety system should be changed

被引：75
作者：
Strom, BL [1 ]
机构：
[1] Univ Penn, Sch Med, Dept Biostat & Epidemiol, Ctr Clin Epidemiol & Biostat, Philadelphia, PA 19104 USA
来源：
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION | 2006年 / 295卷 / 17期
关键词：
D O I：
10.1001/jama.295.17.2072
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：2072 / 2075
页数：4
相关论文
共 19 条
  • [11] THE NATURE OF ADVERSE EVENTS IN HOSPITALIZED-PATIENTS - RESULTS OF THE HARVARD MEDICAL-PRACTICE STUDY-II
    LEAPE, LL
    BRENNAN, TA
    LAIRD, N
    LAWTHERS, AG
    LOCALIO, AR
    BARNES, BA
    HEBERT, L
    NEWHOUSE, JP
    WEILER, PC
    HIATT, H
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1991, 324 (06) : 377 - 384
  • [12] Changes in isotretinoin prescribing before and after implementation of the System to Manage Accutane Related Teratogenicity™ (SMART™) risk management program
    Mendelsohn, AB
    Governale, L
    Trontell, A
    Seligman, P
    [J]. PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2005, 14 (09) : 615 - 618
  • [13] *PHRMA, 2004, PHARM IND PROF 2004
  • [14] Rawlins JW., 1977, TXB ADVERSE DRUG REA, P44
  • [15] Promotion of prescription drugs to consumers.
    Rosenthal, MB
    Berndt, ER
    Donohue, JM
    Frank, RG
    Epstein, AM
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2002, 346 (07) : 498 - 505
  • [16] Direct-to-consumer advertising of COX-2 inhibitors: Effect on appropriateness of prescribing
    Spence, MM
    Teleki, SS
    Cheetham, TC
    Schweitzer, SO
    Millares, M
    [J]. MEDICAL CARE RESEARCH AND REVIEW, 2005, 62 (05) : 544 - 559
  • [17] Strom BL, 2005, PHARMACOEPIDEMIOLOGY, 4TH EDITION, P29
  • [18] Strom BL, 2005, PHARMACOEPIDEMIOLOGY, 4TH EDITION, P219
  • [19] *US GEN ACC OFF, 1990, PUBL GAO, P24
12